Affinia Therapeutics
About Affinia Therapeutics
Affinia Therapeutics is an innovative biotechnology company pioneering adeno-associated virus (AAV) gene therapies. The company focuses on developing transformative therapies for heart and nervous system diseases, utilizing artificial intelligence to design novel capsids that enhance the efficacy and safety of gene therapies.
Business Information
Target Customers
Industry Categories
Business Model
Funding Timeline
Round | Date | Amount | Investors |
---|---|---|---|
Series C | Oct 08, 2025 | $40.0M | Unknown |
Founders
No founder information available.
Investors
No investor information available.
Recent Mentions
New Raise 🏛️ Company: Affinia Therapeutics 🔗 Website: https://t.co/UmzHBcvFeX 📊 Amount: $40 Million 🔄 Round: Series C 🧮 Valuation: N/A ⚙️ Industry: Biotechnology
Similar Startups
Axon Therapies
88% matchAxon Therapies is a biotechnology startup focused on developing innovative therapies for neurologica...
Axon Therapeutics
88% matchAxon Therapeutics is a pioneering company in the Medical Technology sector, focused on developing in...
Avenzo Therapeutics
88% matchAvenzo Therapeutics is a biotechnology company focused on developing innovative therapies to address...
Avammune Therapeutics
87% matchAvammune Therapeutics is a biopharmaceutical company focused on small molecule drug discovery and de...